These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 33275738)

  • 21. [Classification and therapeutic management of monoclonal gammopathies of renal significance].
    Javaugue V; Bouteau I; Sirac C; Quellard N; Diolez J; Colombo A; Desport E; Ecotière L; Goujon JM; Fermand JP; Touchard G; Jaccard A; Bridoux F
    Rev Med Interne; 2018 Mar; 39(3):161-170. PubMed ID: 28457684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rituximab failure in a patient with monoclonal gammopathy of undetermined significance (MGUS)-associated acquired von Willebrand syndrome.
    Grimaldi D; Bartolucci P; Gouault-Heilmann M; Martin-Toutain I; Khellaf M; Godeau B
    Thromb Haemost; 2008 Apr; 99(4):782-3. PubMed ID: 18392339
    [No Abstract]   [Full Text] [Related]  

  • 23. [Diagnosis and treatment of kidney involvement in plasma cell diseases : Renal involvement in multiple myeloma and monoclonal gammopathies].
    Gödecke V; Schmidt JJ; Bräsen JH; Koenecke C; Haller H
    Internist (Berl); 2019 Jan; 60(1):10-22. PubMed ID: 30635666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal Gammopathy-Associated Peripheral Neuropathy: Diagnosis and Management.
    Chaudhry HM; Mauermann ML; Rajkumar SV
    Mayo Clin Proc; 2017 May; 92(5):838-850. PubMed ID: 28473042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Scope of Kidney Affection in Monoclonal Gammopathies at All Levels of Clinical Significance.
    Mehtat Ünlü Ş; Özsan H; Sarıoğlu S
    Turk J Haematol; 2017 Dec; 34(4):282-288. PubMed ID: 28832010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal IgM Gammopathy and Waldenström's Macroglobulinemia.
    Grunenberg A; Buske C
    Dtsch Arztebl Int; 2017 Nov; 114(44):745-751. PubMed ID: 29169431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal Gammopathy of Renal Significance.
    Leung N; Bridoux F; Nasr SH
    N Engl J Med; 2021 May; 384(20):1931-1941. PubMed ID: 34010532
    [No Abstract]   [Full Text] [Related]  

  • 28. Managing scleromyxedema with intravenous immunoglobulin: acute worsening of scleromyxedema with biclonal gammopathy.
    Manousaridis I; Loeser C; Goerdt S; Hassel JC
    Acta Dermatovenerol Alp Pannonica Adriat; 2010 Dec; 19(4):15-9. PubMed ID: 21390475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New aspects on the pathogenesis of renal disorders related to monoclonal gammopathies.
    Kapoulas S; Raptis V; Papaioannou M
    Nephrol Ther; 2015 Jun; 11(3):135-43. PubMed ID: 25861714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spectrum of manifestations of monoclonal gammopathy-associated renal lesions.
    Sethi S; Fervenza FC; Rajkumar SV
    Curr Opin Nephrol Hypertens; 2016 Mar; 25(2):127-37. PubMed ID: 26735145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Monoclonal gammopathies: differential diagnosis with bone marrow biopsy].
    Faravelli A; Ponzoni M; Zoldan MC; Ricci D; Camba L
    Pathologica; 1994 Jun; 86(3):258-66. PubMed ID: 7808796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal gammopathy of undetermined significance.
    Mouhieddine TH; Weeks LD; Ghobrial IM
    Blood; 2019 Jun; 133(23):2484-2494. PubMed ID: 31010848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Recommendations for the management of monoclonal gammopathies in biochemistry].
    Oudart JB; Maquart FX; Ramont L
    Ann Biol Clin (Paris); 2012; 70(3):251-61. PubMed ID: 22565172
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal gammopathy and neuropathy.
    Ramchandren S; Lewis RA
    Curr Opin Neurol; 2009 Oct; 22(5):480-5. PubMed ID: 19625962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acquired peripheral neuropathies associated with monoclonal gammopathy].
    Gajos A; Kieliś W; Szadkowska I; Chmielowska E; Niewodniczy A; Bogucki A
    Neurol Neurochir Pol; 2007; 41(2):169-75. PubMed ID: 17530580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal gammopathy with significance: case series and literature review.
    Schoot TS; van Apeldoorn M; Sinnige HAM; Beutler JJ
    Neth J Med; 2020 Jul; 78(4):191-195. PubMed ID: 32641558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal gammopathy of renal significance: clinical manifestation, pathogenic characteristic and treatment.
    Cao Q; Qi H; Yao L; Liu Q
    Panminerva Med; 2020 Mar; 62(1):38-53. PubMed ID: 30848114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CANOMAD: a neurological monoclonal gammopathy of clinical significance that benefits from B-cell-targeted therapies.
    Le Cann M; Bouhour F; Viala K; Simon L; Tard C; Rossi C; Morel G; Lagrange E; Magy L; Créange A; Michaud M; Franques J; Echaniz-Laguna A; Antoine JC; Baron M; Arnulf B; Puma A; Delmont E; Maisonobe T; Leblond V; Roos-Weil D
    Blood; 2020 Nov; 136(21):2428-2436. PubMed ID: 32959046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C3 glomerulonephritis associated with monoclonal gammopathy of renal significance: case report.
    Alonso-Titos J; Perea-Ortega L; Sola E; Torres-Rueda A; León M; Toledo R; Duarte AD; Vazquez T; Martinez-Esteban MD; Bailen A; Ruiz-Esteban P; Hernandez D
    BMC Nephrol; 2018 Jun; 19(1):129. PubMed ID: 29884135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal gammopathies: Electronic subspecialty consultation.
    Burwick N; Stein J; Garcia DA; Broudy VC; Richard RE
    Eur J Haematol; 2018 Apr; 100(4):351-355. PubMed ID: 29281132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.